TY - JOUR AU - Omuro, A. AU - DeAngelis, L. M. PY - 2013 DA - 2013// TI - Glioblastoma and other malignant gliomas: a clinical review JO - Jama. VL - 310 UR - https://doi.org/10.1001/jama.2013.280319 DO - 10.1001/jama.2013.280319 ID - Omuro2013 ER - TY - JOUR AU - Stupp, R. AU - Mason, W. P. AU - Bent, M. J. PY - 2005 DA - 2005// TI - Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma JO - N Engl J Med VL - 352 UR - https://doi.org/10.1056/NEJMoa043330 DO - 10.1056/NEJMoa043330 ID - Stupp2005 ER - TY - JOUR AU - Wick, W. AU - Hartmann, C. AU - Engel, C. PY - 2009 DA - 2009// TI - NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with procarbazine, lomustine, and vincristine or temozolomide JO - J Clin Oncol VL - 27 UR - https://doi.org/10.1200/JCO.2009.23.6497 DO - 10.1200/JCO.2009.23.6497 ID - Wick2009 ER - TY - STD TI - Bell EH, Zhang P, Fisher BJ, et al. Association of MGMT promoter methylation status with survival outcomes in patients with high-risk glioma treated with radiotherapy and Temozolomide: an analysis from the NRG oncology/RTOG 0424 trial. JAMA Oncol. 2018. ID - ref4 ER - TY - JOUR AU - Gorlia, T. AU - Bent, M. J. AU - Hegi, M. E. PY - 2008 DA - 2008// TI - Nomograms for predicting survival of patients with newly diagnosed glioblastoma: prognostic factor analysis of EORTC and NCIC trial 26981-22981/CE.3 JO - Lancet Oncol VL - 9 UR - https://doi.org/10.1016/S1470-2045(07)70384-4 DO - 10.1016/S1470-2045(07)70384-4 ID - Gorlia2008 ER - TY - JOUR AU - Hegi, M. E. AU - Diserens, A. C. AU - Gorlia, T. PY - 2005 DA - 2005// TI - MGMT gene silencing and benefit from temozolomide in glioblastoma JO - N Engl J Med VL - 352 UR - https://doi.org/10.1056/NEJMoa043331 DO - 10.1056/NEJMoa043331 ID - Hegi2005 ER - TY - JOUR AU - Quillien, V. AU - Lavenu, A. AU - Sanson, M. PY - 2014 DA - 2014// TI - Outcome-based determination of optimal pyrosequencing assay for MGMT methylation detection in glioblastoma patients JO - J Neuro-Oncol VL - 116 UR - https://doi.org/10.1007/s11060-013-1332-y DO - 10.1007/s11060-013-1332-y ID - Quillien2014 ER - TY - JOUR AU - Bady, P. AU - Sciuscio, D. AU - Diserens, A. C. PY - 2012 DA - 2012// TI - MGMT methylation analysis of glioblastoma on the Infinium methylation BeadChip identifies two distinct CpG regions associated with gene silencing and outcome, yielding a prediction model for comparisons across datasets, tumor grades, and CIMP-status JO - Acta Neuropathol VL - 124 UR - https://doi.org/10.1007/s00401-012-1016-2 DO - 10.1007/s00401-012-1016-2 ID - Bady2012 ER - TY - JOUR AU - Lambin, P. AU - Leijenaar, R. T. H. AU - Deist, T. M. PY - 2017 DA - 2017// TI - Radiomics: the bridge between medical imaging and personalized medicine JO - Nat Rev Clin Oncol VL - 14 UR - https://doi.org/10.1038/nrclinonc.2017.141 DO - 10.1038/nrclinonc.2017.141 ID - Lambin2017 ER - TY - JOUR AU - Liu, Z. AU - Wang, Y. AU - Liu, X. PY - 2018 DA - 2018// TI - Radiomics analysis allows for precise prediction of epilepsy in patients with low-grade gliomas JO - Neuroimage Clin VL - 19 UR - https://doi.org/10.1016/j.nicl.2018.04.024 DO - 10.1016/j.nicl.2018.04.024 ID - Liu2018 ER - TY - JOUR AU - Hwan-Ho, C. AU - Hyunjin, P. PY - 2017 DA - 2017// TI - Classification of low-grade and high-grade glioma using multi-modal image radiomics features JO - Conf Proc IEEE Eng Med Biol Soc VL - 2017 ID - Hwan-Ho2017 ER - TY - JOUR AU - Han, Y. AU - Xie, Z. AU - Zang, Y. PY - 2018 DA - 2018// TI - Non-invasive genotype prediction of chromosome 1p/19q co-deletion by development and validation of an MRI-based radiomics signature in lower-grade gliomas JO - J Neuro-Oncol VL - 140 UR - https://doi.org/10.1007/s11060-018-2953-y DO - 10.1007/s11060-018-2953-y ID - Han2018 ER - TY - JOUR AU - Li, Z. C. AU - Bai, H. AU - Sun, Q. PY - 2018 DA - 2018// TI - Multiregional radiomics features from multiparametric MRI for prediction of MGMT methylation status in glioblastoma multiforme: a multicentre study JO - Eur Radiol VL - 28 UR - https://doi.org/10.1007/s00330-017-5302-1 DO - 10.1007/s00330-017-5302-1 ID - Li2018 ER - TY - JOUR AU - Xi, Y. B. AU - Guo, F. AU - Xu, Z. L. PY - 2018 DA - 2018// TI - Radiomics signature: a potential biomarker for the prediction of MGMT promoter methylation in glioblastoma JO - J Magn Reson Imaging VL - 47 UR - https://doi.org/10.1002/jmri.25860 DO - 10.1002/jmri.25860 ID - Xi2018 ER - TY - BOOK AU - Wei, J. AU - Yang, G. PY - 2018 DA - 2018// TI - Hao X, et al PB - A multi-sequence and habitat-based MRI radiomics signature for preoperative prediction of MGMT promoter methylation in astrocytomas with prognostic implication CY - Eur Radiol ID - Wei2018 ER - TY - JOUR AU - Kickingereder, P. AU - Neuberger, U. AU - Bonekamp, D. PY - 2018 DA - 2018// TI - Radiomic subtyping improves disease stratification beyond key molecular, clinical, and standard imaging characteristics in patients with glioblastoma JO - Neuro-Oncology VL - 20 UR - https://doi.org/10.1093/neuonc/nox188 DO - 10.1093/neuonc/nox188 ID - Kickingereder2018 ER - TY - JOUR AU - Yoon, J. H. AU - Kim, J. H. AU - Kang, W. J. PY - 2014 DA - 2014// TI - Grading of cerebral glioma with multiparametric MR imaging and 18F-FDG-PET: concordance and accuracy JO - Eur Radiol VL - 24 UR - https://doi.org/10.1007/s00330-013-3019-3 DO - 10.1007/s00330-013-3019-3 ID - Yoon2014 ER - TY - STD TI - Ideguchi M, Nishizaki T, Ikeda N, et al. A surgical strategy using a fusion image constructed from 11C-methionine PET, 18F-FDG-PET and MRI for glioma with no or minimum contrast enhancement. J Neuro-Oncol. 2018. ID - ref18 ER - TY - JOUR AU - Dankbaar, J. W. AU - Snijders, T. J. AU - Robe, P. A. PY - 2015 DA - 2015// TI - The use of 18F-FDG PET to differentiate progressive disease from treatment induced necrosis in high grade glioma JO - J Neuro-Oncol VL - 125 UR - https://doi.org/10.1007/s11060-015-1883-1 DO - 10.1007/s11060-015-1883-1 ID - Dankbaar2015 ER - TY - JOUR AU - Santra, A. AU - Kumar, R. AU - Sharma, P. AU - Bal, C. AU - Julka, P. K. AU - Malhotra, A. PY - 2011 DA - 2011// TI - F-18 FDG PET-CT for predicting survival in patients with recurrent glioma: a prospective study JO - Neuroradiology. VL - 53 UR - https://doi.org/10.1007/s00234-011-0898-3 DO - 10.1007/s00234-011-0898-3 ID - Santra2011 ER - TY - JOUR AU - Choi, H. AU - Bang, J. I. AU - Cheon, G. J. PY - 2015 DA - 2015// TI - (1)(8)F-fluorodeoxyglucose and (1)(1)C-methionine positron emission tomography in relation to methyl-guanine methyltransferase promoter methylation in high-grade gliomas JO - Nucl Med Commun VL - 36 UR - https://doi.org/10.1097/MNM.0000000000000236 DO - 10.1097/MNM.0000000000000236 ID - Choi2015 ER - TY - JOUR AU - Colavolpe, C. AU - Guedj, E. AU - Metellus, P. PY - 2008 DA - 2008// TI - FDG-PET to predict different patterns of progression in multicentric glioblastoma: a case report JO - J Neuro-Oncol VL - 90 UR - https://doi.org/10.1007/s11060-008-9629-y DO - 10.1007/s11060-008-9629-y ID - Colavolpe2008 ER - TY - JOUR AU - Bent, M. J. AU - Dubbink, H. J. AU - Sanson, M. PY - 2009 DA - 2009// TI - MGMT promoter methylation is prognostic but not predictive for outcome to adjuvant PCV chemotherapy in anaplastic oligodendroglial tumors: a report from EORTC brain tumor group study 26951 JO - J Clin Oncol VL - 27 UR - https://doi.org/10.1200/JCO.2009.24.1034 DO - 10.1200/JCO.2009.24.1034 ID - Bent2009 ER - TY - JOUR AU - Bent, M. J. AU - Baumert, B. AU - Erridge, S. C. PY - 2017 DA - 2017// TI - Interim results from the CATNON trial (EORTC study 26053-22054) of treatment with concurrent and adjuvant temozolomide for 1p/19q non-co-deleted anaplastic glioma: a phase 3, randomised, open-label intergroup study JO - Lancet. VL - 390 UR - https://doi.org/10.1016/S0140-6736(17)31442-3 DO - 10.1016/S0140-6736(17)31442-3 ID - Bent2017 ER - TY - JOUR AU - Reifenberger, G. AU - Hentschel, B. AU - Felsberg, J. PY - 2012 DA - 2012// TI - Predictive impact of MGMT promoter methylation in glioblastoma of the elderly JO - Int J Cancer VL - 131 UR - https://doi.org/10.1002/ijc.27385 DO - 10.1002/ijc.27385 ID - Reifenberger2012 ER - TY - JOUR AU - Griethuysen, J. J. M. AU - Fedorov, A. AU - Parmar, C. PY - 2017 DA - 2017// TI - Computational Radiomics system to decode the radiographic phenotype JO - Cancer Res VL - 77 UR - https://doi.org/10.1158/0008-5472.CAN-17-0339 DO - 10.1158/0008-5472.CAN-17-0339 ID - Griethuysen2017 ER - TY - JOUR AU - Suh, H. B. AU - Choi, Y. S. AU - Bae, S. PY - 2018 DA - 2018// TI - Primary central nervous system lymphoma and atypical glioblastoma: differentiation using radiomics approach JO - Eur Radiol VL - 28 UR - https://doi.org/10.1007/s00330-018-5368-4 DO - 10.1007/s00330-018-5368-4 ID - Suh2018 ER - TY - STD TI - Kong Z, Jiang C, Zhu R, et al. 18F-FDG-PET-based radiomics features to distinguish primary central nervous system lymphoma from glioblastoma. NeuroImage: Clinical. 2019;101912. ID - ref28 ER - TY - JOUR AU - Vickers, A. J. AU - Elkin, E. B. PY - 2006 DA - 2006// TI - Decision curve analysis: a novel method for evaluating prediction models JO - Med Decis Mak VL - 26 UR - https://doi.org/10.1177/0272989X06295361 DO - 10.1177/0272989X06295361 ID - Vickers2006 ER - TY - JOUR AU - Zhang, Z. AU - Rousson, V. AU - Lee, W. C. PY - 2018 DA - 2018// TI - Decision curve analysis: a technical note JO - Ann Transl Med VL - 6 UR - https://doi.org/10.21037/atm.2018.07.02 DO - 10.21037/atm.2018.07.02 ID - Zhang2018 ER - TY - JOUR AU - Drabycz, S. AU - Roldan, G. AU - Robles, P. PY - 2010 DA - 2010// TI - An analysis of image texture, tumor location, and MGMT promoter methylation in glioblastoma using magnetic resonance imaging JO - Neuroimage. VL - 49 UR - https://doi.org/10.1016/j.neuroimage.2009.09.049 DO - 10.1016/j.neuroimage.2009.09.049 ID - Drabycz2010 ER - TY - JOUR AU - Carrillo, J. A. AU - Lai, A. AU - Nghiemphu, P. L. PY - 2012 DA - 2012// TI - Relationship between tumor enhancement, edema, IDH1 mutational status, MGMT promoter methylation, and survival in glioblastoma JO - AJNR Am J Neuroradiol VL - 33 UR - https://doi.org/10.3174/ajnr.A2950 DO - 10.3174/ajnr.A2950 ID - Carrillo2012 ER - TY - JOUR AU - Romano, A. AU - Calabria, L. F. AU - Tavanti, F. PY - 2013 DA - 2013// TI - Apparent diffusion coefficient obtained by magnetic resonance imaging as a prognostic marker in glioblastomas: correlation with MGMT promoter methylation status JO - Eur Radiol VL - 23 UR - https://doi.org/10.1007/s00330-012-2601-4 DO - 10.1007/s00330-012-2601-4 ID - Romano2013 ER - TY - JOUR AU - Han, Y. AU - Yan, L. -. F. AU - Wang, X. -. B. PY - 2018 DA - 2018// TI - Structural and advanced imaging in predicting MGMT promoter methylation of primary glioblastoma: a region of interest based analysis JO - BMC Cancer VL - 18 UR - https://doi.org/10.1186/s12885-018-4114-2 DO - 10.1186/s12885-018-4114-2 ID - Han2018 ER - TY - JOUR AU - Maher, E. A. AU - Marin-Valencia, I. AU - Bachoo, R. M. PY - 2012 DA - 2012// TI - Metabolism of [U-13 C]glucose in human brain tumors in vivo JO - NMR Biomed VL - 25 UR - https://doi.org/10.1002/nbm.2794 DO - 10.1002/nbm.2794 ID - Maher2012 ER - TY - JOUR AU - Kim, M. M. AU - Parolia, A. AU - Dunphy, M. P. AU - Venneti, S. PY - 2016 DA - 2016// TI - Non-invasive metabolic imaging of brain tumours in the era of precision medicine JO - Nat Rev Clin Oncol VL - 13 UR - https://doi.org/10.1038/nrclinonc.2016.108 DO - 10.1038/nrclinonc.2016.108 ID - Kim2016 ER - TY - JOUR AU - Lee, J. W. AU - Lee, S. M. PY - 2018 DA - 2018// TI - Radiomics in oncological PET/CT: clinical applications JO - Nucl Med Mol Imaging VL - 52 UR - https://doi.org/10.1007/s13139-017-0500-y DO - 10.1007/s13139-017-0500-y ID - Lee2018 ER -